Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
A phase 3 trial demonstrates multiple benefits of adding the androgen-receptor inhibitor darolutamide to standard therapy.
Prostate cancer is a malignant growth in the prostate (a sex gland in men found below the bladder and in front of the rectum).
Massachusetts General Hospital's Pain Management Center offers advanced pain management therapies for patients experiencing moderate to severe levels of cancer-related pain.
Claire & John Bertucci
The Claire & John Bertucci Center for Genitourinary Cancers is one of the largest, most experienced centers in New England for the treatment and care of patients with bladder, kidney, prostate and other genitourinary cancers.
Oncological treatment therapies are interventions given before or after tumor surgery to maximize the effectiveness of cancer treatment, including chemotherapy, radiation and the newer targeted and biological therapies.
Mass General Brigham has one of the few PET-MRI scanners in the country. PET-MRI services are available in Boston.
Helps to identify and provide comprehensive, coordinated medical care for families that have a hereditary predisposition to prostate cancer.
Experts in our program offer care for slow-growing and aggressive forms of prostate cancer.
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.